The Centers for Medicare & Medicaid Services finalized more than 4,000 pages worth of 2020 payment regulations last week, with some important implications for device firms. In this edition of Pathways’ Picks, a look at some key policy decisions in the rules, with a focus on medtech disappointments tied to policies countering the opioid epidemic. Also, more news to watch and dates to remember.
CMS wrestled with the opioid abuse epidemic in its latest round of annual payment rules, but device firms’ efforts to better position medical technologies as alternatives to opioids for treating pain were mostly unsuccessful. Those outcomes lead this week’s Pathways’ Picks—a rundown of medtech policy happenings and key dates that should be on your radar.